‘Patterns’ of COVID-19 Coronavirus Infection in Pregnant Women in Physician Practice
Gulbanu Shaimerdenova 1 * More Detail
1 1Department of Infectious Diseases and Dermatovenerology, South Kazakhstan Medical Academy, Shymkent, Kazakhstan
* Corresponding Author
J CLIN MED KAZ, Volume 21, Issue 4, pp. 66-70.
https://doi.org/10.23950/jcmk/14970
OPEN ACCESS
534 Views
273 Downloads
ABSTRACT
Objectives: Evaluation of the Effectiveness of Developed Algorithms for Managing Pregnant Women and Assessing Severity Using the WHO ABCDE Approach During COVID-19 Among Practicing Physicians
Material and methods:
To evaluate the effectiveness of the algorithm for managing pregnant women and assessing severity using the WHO ABCDE approach during COVID-19, we analyzed 102 medical records of pregnant patients with COVID-19 who received treatment in infectious disease hospitals and perinatal centers in the city of Shymkent from January to April 2022.
Results: Diagnostic errors were made in 22.5% of the sample before the training on the developed algorithms. Following the training sessions, the error rate decreased by 7.8%. Physicians identified errors in the following diagnoses: influenza - 10.8% (11 cases), acute intestinal infections - 4.9% (5 cases), acute cerebrovascular accident, measles, and atypical pneumonia - 1.9% (2 cases each), and Kawasaki disease - 0.9% (1 case). After the training, the incidence of the diagnosis of "Influenza" decreased by 4.9% and "Acute intestinal infections" by 3%.
Our findings revealed that the percentage of diagnostic errors (underdiagnosis) significantly dropped from 41.2±6.9% (n=51) to 11.6%±4.9 (p<0.01) (n=43), representing a reduction of more than 3.6 times. The analysis of diagnostic errors related to the underdiagnosis of COVID-19 and the implementation of the algorithm for the management and severity assessment based on the WHO ABCDE approach led to a more than 3.6-fold decrease in cases of delayed diagnosis.
Conclusions: The analysis of diagnostic errors related to the underdiagnosis of COVID-19 and the implementation of the management and severity assessment algorithm based on the WHO ABCDE approach led to a more than 3.6-fold reduction in the number of delayed diagnoses.
REFERENCES
- World Health Organization. Novel coronavirus (2019- nCoV). Situation report 22. Available at: https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200211-sitrep-22-ncov.pdf?sfvrsn=fb6d49b1_2. 11 February 2020.
- «There is an increasing number of cases in several EU/EEA countries without epidemiological links to explain the source of transmission» Daily risk assessment on COVID-19 ECPC, 13 March 2020.
- Data of the committee for sanitary and epidemiological control of the city of Shymkent, 2024 [in Russian]. https://rk-ncph.kz/ru/sanepidem/ezhemesyachnaya-situatsiya.
- Kumar D, Verma S, Mysorekar IU. COVID-19 and pregnancy: clinical outcomes; mechanisms, and vaccine efficacy. Transl Res. 2022; 12: S1931-5244(22)00180-3. https://doi.org/10.1016/j.trsl.2022.08.007.
- Hong L, Smith N.,Keerthy M., Lee-Griffith M.,Garsia R et al. Severe COVID-19 infection in Pregnancy Recuiring Intubation without Preterm Delivery: A Case Report. Case Reports in Womens Health. 2020; 27: e00217. https://doi.org/10.1016/j.crwh.2020.e00217.
- Khateeb J, Li Y, Zhang H. Emerging SARS-CoV-2 variants of concern and potential intervention approaches. Crit Care. 2021; 25(1): 244. https://doi.org/10.1186/s13054-021-03662-x
- Garazhayeva L, Gaipov A, Kauysheva A. Assessing the impact of COVID-19 on renal health in recovered patients: a multi-center longitudinal study. J Clin Med Kaz. 2024; 21(2): 31–35. https://doi.org/10.23950/jcmk/14566.
- Clinical protocol for the diagnosis and treatment of coronavirus infection COVID-19 in pregnant women, women in labor and puerperas of August 5, 2021. Available at: http://www.rcrz.kz/index.php/ru/2017-03-12-10-50-44/ press-reliz/2365-press-reliz.16.07.2022.
- Ganikyzy Shaimerdenova G, Narkenovna Abuova G, Nalibekkyzy Kulbayeva S. Features of the course of severe and critical COVID-19 in pregnant women: A prospective cross-sectional study. Int J Reprod BioMed. 2024; 22: 1–6. https://doi.org/10.18502/23-2-8.
- Clinic of COVID-19 in pregnant women. Principles of treatment in infectious disease hospitals of Shymkent [in Russian]. Aktualnye problemy teoreteticheskoy i klinicheskoy mediciny. 2021; 1: 59–62.
- Abuova GN, Khangeldy KZh, Shaimerdenova GG, Zhorakhanova BA, Sadykhova DK. Efficacy of the antiviral drug enisamy iodide in severe adult acute respiratory infections in the COVID-19 era. Nauka i Zdravookhranenie [Science & Healthcare]. 2024; 26 (1): 125–131. https://doi.org/10.34689/SH.2024.26.1.016.
- Ismail NF, Rahman AE, Kulkarni D et al Incidence and outcome of SARS-CoV-2 reinfection in the pre-Omicron era: A global systematic review and meta-analysis. J Glob Health. 2023; 13: 06051. https://doi.org/10.7189/jogh.13.06051.
- Bayakhmetova M, Abuova GN, Biniyazova AA, Bukharbayev YB, Ablyazimov TN, Seitkhanova BT. Knowledge and perceptions of infectious disease physicians about epidemiology, causes, diagnosis, treatment and prevention of Q fever in the Republic of Kazakhstan: results of online survey. J Clin Med Kaz. 2024; 21(2): 36–40. https://doi.org/10.23950/jcmk/14499.
- Van den Berg P, Schechter-Perkins EM, Jack RS et al Effectiveness of 3 Versus 6 ft of Physical Distancing for Controlling Spread of Coronavirus Disease 2019 Among Primary and Secondary Students and Staff: A Retrospective, Statewide Cohort Study. Clin Infect Dis. 2021; 73(10): 1871–1878. Erratum in: Clin Infect Dis. 2022; 74(6): 1127–1129. https://doi.org/10.1093/cid/ciab230.
- The impact of coronavirus infection COVID-19 on the course of pregnancy in the city of Shymkent: a case study [in Russian]. Pharmacy. 2022; 5 (244): 5–10. https://doi.org/10.53511/pharmkaz.2022.10.48.001.
- Successful apply of ECMO among in pregnant women with COVID-19: a case study [in Russian]. Pharmacy. 2022; 5 (244): 83–86.
- Karakoyun A, Bahadır Yılmaz E, Yüksel A. Relationship between coronavirus anxiety, resilience, and attitudes toward complementary and alternative treatment among patients admitted to the COVID-19 Outpatient Clinic. J Clin Med Kaz. 2024; 21(1): 61–66. https://doi.org/10.23950/jcmk/14272.
- Elshafeey F, Magdi R, Hindi N, Elshebiny M, Farrag N, Mahdy S, et al. A systematic scoping review of COVID19 during pregnancy and childbirth. Int J Gynecol Obstet. 2020; 150: 47–52. https://doi.org/10.1002/ijgo.13182.
- Ayazbekov A, Nurkhasimova R, Kulbayeva S, Bolat K, Kurmanova AM, Yeskarayeva A, et al. Features of pregnancy, childbirth and postpartum period of young mothers. Electron J Gen Med. 2020; 17: em260. https://doi.org/10.29333/ejgm/8459
- Joseph NT, Collier AY. COVID-19 therapeutics and considerations for pregnancy. Obstet Gynecol Clin North Am. 2023; 50: 163–182. https://doi.org/10.1016/j.ogc.2022.10.018.
- Rasmussen SA, Smulian JC, Lednicky JA, Wen TS, Jamieson DJ. Coronavirus Disease 2019 (COVID-19) and pregnancy: What obstetricians need to know. Am J Obstet Gynecol. 2020; 222: 415–426. https://doi.org/10.1016/j.ajog.2020.02.017.
- Bayakhmetova M, Abuova GN, Bukharbayev YB, Ablyazimov TN, Kamytbekova KZ, Baimbetova S. Q fever in individuals in the Eurasian continent: A 50-year literature review (1973-2022). Arch Clin Infect Dis. 2023; 18: e136333. https://doi.org/10.5812/archcid-136333.
- Kurmanova A, Urazbayeva G, Terlikbayeva A, Salimbaeva D, Ayazbekov A. Diagnostic significance of blood lymphocyte activation markers in pre-eclampsia. Clin Exp Immunol. 2024; 215: 94–103. https://doi.org/10.1093/cei/uxad121.
- Misra DP, Zimba O, Gasparyan AY. Statistical data presentation: A primer for rheumatology researchers. Rheumatol Int. 2021; 41: 43–55. https://doi.org/10.1007/s00296-020-04740-z.